Lot aahe541 and lot aahb006 manufactured 12/30/2020, expires 12/29/2025, udi code were used for the procedure.The review of the device history records confirmed the finished goods and components met all requirements throughout the incoming inspection, manufacturing, in-process and final inspection processes.No sterile samples were returned for testing/review.No retained samples were available for review.No photos of the surgical site(s), patient's incisions were provided for review.If samples and/or photos become available, the samples will be tested, photos will be reviewed and the results will be documented in the file.A follow-up report will be submitted at that time.The "precautions" section of the ifu states, "infections, erythema, foreign body reactions, spitting transient inflammatory reactions and in rare instances wound dehiscence are typical or foreseeable risks associated with any suture and hence are also potential complications associated with polysyn¿ (polyglycolic acid) suture".The ¿adverse reactions¿ section of the ifu for the pga devices states, ¿adverse effects associated with the use of this device may include, wound dehiscence, failure to provide adequate wound support in closure of the site where expansion, stretching or distension occur, failure to provide adequate wound support in elderly, malnourished or debilitated patients or in patients suffering from condition which may delay wound healing, infection, minimal acute inflammatory tissue reaction, localized in tissue with poor blood supply, calculi formation in urinary and biliary tracts when prolonged contact with salt solutions such as urine and bile occurs and transitory local infection at the wound site¿.The "actions" section of the ifu for this material states, "poly"syn¿ (polyglycolic acid) suture elicits a minimal acute inflammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fibrous connective tissue.Progressive loss of tensile strength and eventual absorption of polysyn¿ (polyglycolic acid) synthetic absorbable sutures occurs by hydrolysis, where the polymer degrades to glycolic acid which is subsequently absorbed and metabolized by the body.Absorption begins as a loss of tensile strength without appreciable loss of mass.Implantation studies in animals indicate that polysyn¿ (polyglycolic acid) suture retains at least 50% of its original tensile strength at two weeks post implantation, with approximately 20% remaining at three weeks.Absorption of polysyn¿ (polyglycolic acid) synthetic absorbable suture is essentially complete between 50 and 90 days.Without receiving photos of the incisions/surgical site, details of the procedures performed, post-operative instructions and/or events that may have occurred resulting in the wound healing difficulties, placement of the devices or the surgeon's technique, a definitive root cause cannot be determined at this time.
|